87
ROCHA, R. M. et al. Construção de arrays de tecido com equipamento alternativo
e de baixo custo para estudo imunoistoquímico de tumores mamários. J Bras
Patol Med Lab, v.42, n.6, p.477-482, dezembro. 2006.
ROSS, J. S.; FLETCHER, J. A. HER-2/neu (c-erb-B2) gene and protein in breast
cancer. Am J Clin Pathol, v.112, n.1 Suppl 1 p.S53-67, Jul, 1999.
ROSSI, S. et al. Rabbit monoclonal antibodies: a comparative study between a
novel category of immunoreagents and the corresponding mouse monoclonal
antibodies. Am J Clin Pathol, v.124, n.2, p.295-302, Aug. 2005.
SAEZ, A. et al. HER-2 gene amplification by chromogenic in situ hybridisation
(CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A
study of two hundred cases. Breast, v.15, n.4, p.519-27, Aug. 2006.
SAPINO, A. et al. Which breast carcinomas need HER-2/neu gene study after
immunohistochemical analysis? Results of combined use of antibodies against
different c-erbB2 protein domains. Histopathology, v.43, n.4, p.354-62, Oct. 2003.
SAPINO, A. et al. Routine assessment of prognostic factors in breast cancer
using a multicore tissue microarray procedure. Virchows Arch, v.449, n.3, p.288-
96, Sep. 2006.
SARTELET, H. et al. Comparison of liquid based cytology and histology for the
evaluation of HER-2 status using immunostaining and CISH in breast carcinoma.
J Clin Pathol, v.58, n.8, p.864-71, Aug. 2005.
SAUTER, G.; MIRLACHER, M. Tissue microarrays for predictive molecular
pathology. J Clin Pathol, v.55, n.8, p.575-6, Aug. 2002.
SCHAIRER, C. et al. Probabilities of death from breast cancer and other causes
among female breast cancer patients. J Natl Cancer Inst, v.96, n.17, p.1311-21,
Sep 1. 2004.
SCHNITT, S. J. Breast cancer in the 21st century: neu opportunities and neu
challenges. Mod Pathol, v.14, n.3, p.213-8, Mar. 2001.
SCHMITT, F. C. Marcadores prognósticos em carcinoma mamário. In: ALVES,
V. A. F.; BACCHI, C. E.; VASSALO, J. Manual de imuno-histoquímica. Sociedade
Brasileira de Patologia, São Paulo, 30-46. 1999.
SEIDAL, T.; BALATON, A. J.; BATTIFORA, H. Interpretation and quantification of
immunostains. Am J Surg Pathol, v.25, n.9, p.1204-7, Sep. 2001.
SELVARAJAN, S. et al. c-erbB-2 (HER-2/neu) immunohistochemistry in invasive
breast cancer: is there concordance between standard sections and tissue
microarrays? Pathology, v.38, n.4, p.316-20, Aug. 2006.
SLAMON, D. J. et al. Human breast cancer: correlation of relapse and survival
with amplification of the HER-2/neu oncogene. Science, v.235, n.4785, p.177-82,
Jan 9. 1987.